Table 1. Clinical and demographical data of study participants.

Participant	Gender	Age of death	Duration of HIV-1 infection (yr) from diagnosis date	Time on HAART (yr)	HAART regimen	CD4 count before death (cells/ul)	Viral load before death (copies/ml)
1	Female	38	16	16	FTC, RPV, TAF	1625	Undetectable
2	Male	68	25	1	FTC, TAF, BIC	165	Undetectable
3	Male	52	1	1	BIC, FTC, TAF	145	136